Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37CA072614-16
Application #
8111443
Study Section
Special Emphasis Panel (NSS)
Program Officer
Mufson, R Allan
Project Start
1997-02-15
Project End
2017-01-31
Budget Start
2012-02-01
Budget End
2013-01-31
Support Year
16
Fiscal Year
2012
Total Cost
$320,588
Indirect Cost
$113,088
Name
University of California San Francisco
Department
Pediatrics
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Dail, Monique; Wong, Jason; Lawrence, Jessica et al. (2014) Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia. Nature 513:512-6
Jain, Nitin; Curran, Emily; Iyengar, Neil M et al. (2014) Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. Clin Cancer Res 20:490-8
North, Matthew; Shuga, Joe; Fromowitz, Michele et al. (2014) Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke. BMC Cancer 14:6
Stieglitz, Elliot; Liu, Y Lucy; Emanuel, Peter D et al. (2014) Mutations in GATA2 are rare in juvenile myelomonocytic leukemia. Blood 123:1426-7
Lu, Jing; Zavorotinskaya, Tatiana; Dai, Yumin et al. (2013) Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation. Blood 122:1610-20
Xu, Jin; Haigis, Kevin M; Firestone, Ari J et al. (2013) Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation. Cancer Discov 3:993-1001
Chang, Tiffany; Krisman, Kimberly; Theobald, Emily Harding et al. (2013) Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice. J Clin Invest 123:335-9
Li, Qing; Bohin, Natacha; Wen, Tiffany et al. (2013) Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness. Nature 504:143-7
Diaz-Flores, Ernesto; Goldschmidt, Hana; Depeille, Philippe et al. (2013) PLC-ýý and PI3K link cytokines to ERK activation in hematopoietic cells with normal and oncogenic Kras. Sci Signal 6:ra105
Shieh, Angell; Ward, Ashley F; Donlan, Kegan L et al. (2013) Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo. Blood 121:4884-93

Showing the most recent 10 out of 27 publications